Drug Trial Radar · NCT01837667
Phase I Study of LB-100 With Docetaxel in Solid Tumors
Last checked: Nov 19, 2026Latest source record: Jan 24, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
29
Actual
Start
Feb 2013
Primary completion
Sep 2016
Study completion Sep 2016
Sponsor
- Lead sponsor
- Lixte Biotechnology Holdings, Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 23, 2013
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to test the safety of an investigational drug called LB-100 for Injection for treatment of solid tumors, when given with or without docetaxel. LB-100 is a small molecule that in laboratory and animal studies has shown activity when used by itself or together with drugs approved to treat some types of cancer (chemotherapeutic agents). Docetaxel is a drug that has been approved for the treatment of some types of cancer; one of the trade names for docetaxel is Taxotere®. The study is in 2 parts. Part 1: Patients will receive injections of LB-100. Part 2: Patients will receive injections of LB-100 and docetaxel. This is the first study where LB-100 for Injection will be used in humans.
Conditions
- Tumors
- Neoplasms
- Cancer
Interventions
LB-100 for InjectionDrug
Part 1 and Part 2: LB-100 for Injection infusion on Days 1,2,3 of each 21 day cycle.
DocetaxelDrug
Part 2: Docetaxel infusion on Day 2 of each 21 day cycle.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of patients with adverse events as a measure of safety and tolerability of LB-100 for Injection treatment plus docetaxel.Time frame: Starting from date of first dose up to 30 days after last dose.
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
City of Hope National Medical Center
Duarte, California
Mayo Clinic
Rochester, Minnesota
Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada
Texas Oncology - Baylor Charles A. Sammons Cancer Center
Dallas, Texas
Texas Oncology - Tyler
Tyler, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.